A digital illustration depicting the concept of a functional HIV cure, with focus on immune system and viral suppression.

HIV Cure: Is a Functional Cure on the Horizon?

"Exploring the Frontiers of HIV Remission: What a Functional Cure Means and the Challenges Ahead"


For decades, HIV has been a formidable adversary, but the landscape of treatment and research has dramatically shifted. Antiretroviral therapy (ART) has transformed HIV from a death sentence into a manageable chronic condition, allowing people to live long and healthy lives. However, ART requires lifelong commitment, and scientists and patients alike are now looking beyond mere management towards a functional cure.

A functional cure, in the context of HIV, means achieving long-term remission without the need for ongoing antiretroviral therapy. It's a state where the virus is either eliminated or suppressed to such low levels that it doesn't cause disease progression or transmission. This is different from a sterilizing cure, which would mean the complete eradication of the virus from the body.

This article examines the exciting developments in HIV research, the innovative strategies being investigated, and the complex challenges that must be overcome to achieve a functional cure. We'll explore the science behind these approaches, from shrinking the latent reservoir to boosting the immune system, and discuss what the future might hold for people living with HIV.

AI Search Multiple angles on this topic

The Ongoing HIV Burden

HIV continues to have substantial health and social effects worldwide. Antiretroviral treatment can manage infection, but a functional cure remains an investigational goal rather than an established standard. The impact therefore includes both the ongoing need for lifelong care and the continuing search for more durable control.

Treatment and Its Limits

The accepted approach to HIV care is antiretroviral therapy, which suppresses viral activity and supports long-term management. This approach has transformed HIV from a once highly lethal condition into a manageable one for many people, but it generally requires continued treatment. A functional cure would seek sustained control without ongoing antiretroviral therapy, although that goal remains uncertain.

From Early Drugs to Cure Research

HIV treatment has progressed from toxic monotherapies to more effective streamlined regimens, including long-acting injectables and research into potential cures. Major milestones include early drug development, the breakthrough of highly active antiretroviral therapy (HAART), and the emergence of modern long-acting medications. Cure research has also distinguished sterilizing cures, which aim to eliminate HIV, from functional cures, in which HIV remains but is controlled without treatment.

Understanding the Challenge: Why a Functional Cure Is So Difficult

A digital illustration depicting the concept of a functional HIV cure, with focus on immune system and viral suppression.

The primary hurdle in achieving a functional cure for HIV lies in the virus's ability to hide within the body. HIV establishes a latent reservoir, a collection of infected cells that remain dormant, primarily in immune cells. These cells are not actively replicating the virus, making them invisible to ART and, often, to the immune system.

When ART is stopped, the latent virus can reactivate, leading to a resurgence of the infection. This reactivation is the biggest obstacle. Scientists are exploring many different ways to achieve a functional cure, including methods to decrease the size of the latent reservoir, enhance the immune system, or teach the body to control the virus.

  • The Latent Reservoir: A hidden pool of dormant, infected cells that can reactivate.
  • Viral Reactivation: The process by which the latent virus becomes active, leading to a resurgence of the infection.
  • Immune System Limitations: Challenges in effectively targeting and eliminating infected cells.
AI Search Multiple angles on this topic

An Active Research Field

Current HIV cure research is investigating ways to achieve durable viral control after treatment. Reviews of the field consider functional cure approaches alongside broader treatment and immunological strategies. Because these approaches remain under investigation, their effectiveness and long-term feasibility have not yet been established.

Why a Cure Remains Difficult

A functional cure is not yet a routine clinical outcome, and research findings should not be treated as proof that a broadly applicable cure is imminent. Experimental strategies may work in selected circumstances without being safe, scalable, or effective for most people with HIV. The gap between an exceptional research result and a dependable treatment remains a central limitation.

Sterilizing and Functional Cure

HIV cure research commonly contrasts a sterilizing cure, which seeks to eradicate HIV from the body, with a functional cure, in which HIV remains but is controlled without antiretroviral therapy. Mathematical modeling has been used to examine the scale of the challenge involved in achieving post-treatment control. Elite controllers and post-treatment controllers provide important biological models because they can suppress HIV without the same treatment pattern as most people. Researchers have also questioned whether the phrase “functional cure” adequately captures the field's scientific and community meanings.

Many different strategies are being investigated to tackle the latent reservoir. The goal is to either shrink it to a size where the virus rarely reactivates, or to train the immune system to control the virus if it does reactivate. Research is complex, with the goal of achieving a functional cure requires a multi-faceted approach.

The Future of HIV: Hope and Continued Research

The journey towards a functional cure for HIV is a complex one, but it's filled with hope and promise. Researchers are making significant progress, and with ongoing dedication and innovation, the dream of a life free from the daily burden of HIV treatment could soon become a reality. The efforts of researchers, coupled with the resilience of those living with HIV, are driving this essential work forward.

AI Search Multiple angles on this topic

A Promising but Unsettled Goal

The prospect of a functional cure is scientifically important, but it should be presented as a developing research objective rather than an available medical solution. Existing treatment has achieved major progress in controlling HIV, while cure research is testing whether control can eventually persist without ongoing therapy. The evidence supports cautious optimism rather than a prediction that a broadly usable cure is near.

Searching for Durable Control

Recent reports describe functional cure as uncommon but feasible and encourage the development of therapeutic strategies that could help more people reach that level of control. Research and innovation in 2025 include long-acting therapies, vaccine progress, and potential functional cures. These developments point toward future HIV management that may become more durable and less dependent on daily treatment, although the path remains investigational.

Beyond the Laboratory

Progress toward an HIV functional cure will depend not only on laboratory discoveries but also on clinical evidence, access, affordability, and equitable delivery. A research advance cannot have broad public-health impact unless people can receive and sustain the resulting intervention. These practical considerations make implementation as important as scientific success.

Exceptional Cases and Their Meaning

A 2025 report described a 48-year-old Indian woman living in Spain, diagnosed HIV positive in 2002, who was reported as a functional cure case after controlling HIV without ever taking antiretroviral therapy. Such cases can generate substantial hope and publicity, but coverage also cautions that one exceptional case is not the final chapter or proof of a broadly available cure. The Treatment Action Group reported that nine people were then considered cured, or very likely cured, in most cases with continued monitoring for HIV returning.

What these remission results add to HIV cure research

These reports show that treatment-free control can persist for a substantial period in selected groups, but the findings describe particular participants and interventions rather than establishing a dependable outcome for everyone. The antibody results also differ by comparison group, so a delay in rebound is not the same as permanent control.[1] [2] [3]

Laboratory candidates and immune-based approaches offer different ways to address persistence, but cell-line activity or improved immune activity does not by itself demonstrate durable control in people. The evidence points to biological promise alongside unresolved barriers to clearing infected cells.[4] [5]

How the strategies and comparisons fit together

A different line of work used long-acting broadly neutralising antibodies and found enhanced HIV-specific T-cell immunity for at least 36 weeks in aviraemic participants. The trial context included treatment interruption, while other antibody trials reported suppression or delayed loss of control over shorter measured periods.[2] [3] [6]

Evidence also has representation limits: a review found women and people with non-B HIV-1 subtypes underrepresented in latency-reversing-agent studies, restricting meaningful subgroup analysis. A phase study recorded RNA increases in some participants, but those observations alone do not establish reservoir clearance or durable remission.[7] [8]

What evidence would clarify durable control

  • How much do TGF-β-related limits on CAR-T and endogenous T-cell activity affect the effectiveness of immune-based approaches?[5]

Terms used in HIV remission research

bNAbs
Broadly neutralising antibodies.[6]

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1038/s41577-018-0085-4, Alternate LINK

Title: Functional Cure Of Hiv: The Scale Of The Challenge

Subject: Energy Engineering and Power Technology

Journal: Nature Reviews Immunology

Publisher: Springer Science and Business Media LLC

Authors: Miles P. Davenport, David S. Khoury, Deborah Cromer, Sharon R. Lewin, Anthony D. Kelleher, Stephen J. Kent

Published: 2018-11-08

Everything You Need To Know

1

What is a functional cure for HIV, and how does it differ from a sterilizing cure?

A functional cure for HIV means achieving long-term remission without needing continuous antiretroviral therapy (ART). In this state, the virus is either suppressed to such low levels that it doesn't cause disease progression or transmission, or it may even be eliminated. This differs from a sterilizing cure, which would involve completely eradicating the virus from the body. The main focus is controlling the virus so that ART isn't necessary for a patient to live a healthy life. Unlike a sterilizing cure that aims to remove every trace of HIV, a functional cure is about managing the infection effectively.

2

Why is it so difficult to achieve a functional cure for HIV?

Achieving a functional cure is difficult primarily because HIV can hide within the body, forming a latent reservoir. This reservoir consists of infected cells that remain dormant, largely unaffected by antiretroviral therapy (ART) and, in many cases, undetected by the immune system. The biggest challenge lies in the potential viral reactivation from this latent reservoir, which can lead to a resurgence of the infection if ART is stopped. This is because ART is designed to target active replication and not latent cells.

3

What is the latent reservoir in HIV, and why is it a major obstacle to finding a cure?

The latent reservoir in HIV is a hidden pool of dormant, infected cells within the body, primarily in immune cells. These cells are not actively replicating the virus, making them invisible to antiretroviral therapy (ART) and often to the immune system. It's a major obstacle because, if ART is stopped, the latent virus can reactivate, leading to a resurgence of the infection. This reactivation is the biggest hurdle, making it difficult to achieve long-term remission.

4

What strategies are being explored to achieve a functional cure for HIV, and what are their goals?

Several strategies are being investigated to tackle the latent reservoir and achieve a functional cure. The goal is to either shrink the latent reservoir to a size where the virus rarely reactivates, or to train the immune system to control the virus if it does reactivate. Approaches include methods to decrease the size of the latent reservoir, enhance the immune system's ability to target and eliminate infected cells, or teach the body to control the virus itself. These strategies seek to manipulate or eliminate the latent reservoir to prevent viral rebound.

5

If Antiretroviral therapy (ART) can manage HIV, why the push for a functional cure?

While Antiretroviral therapy (ART) has transformed HIV into a manageable chronic condition, it requires lifelong commitment and can come with its own set of challenges, including potential side effects and the burden of daily medication. The push for a functional cure aims to go beyond mere management, offering the possibility of long-term remission without the need for ongoing ART. This would significantly improve the quality of life for people living with HIV, eliminating the need for continuous medication and reducing the risk of drug-related complications. Additionally, a functional cure could potentially reduce the risk of onward transmission, further contributing to the fight against the epidemic. This long-term solution eliminates the daily burden of HIV treatment.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.